本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corbus Pharmaceuticals Holdings, Inc.

10.14
-0.0300-0.29%
盘后9.94-0.2000-1.97%16:28 EDT
成交量:26.81万
成交额:276.20万
市值:1.80亿
市盈率:-1.72
高:10.67
开:10.36
低:9.97
收:10.17
52周最高:20.56
52周最低:4.64
股本:1,773.65万
流通股本:1,274.79万
量比:1.18
换手率:2.10%
股息:- -
股息率:- -
每股收益(TTM):-5.9000
每股收益(LYR):-5.9000
净资产收益率:-54.18%
总资产收益率:-32.91%
市净率:1.22
市盈率(LYR):-1.72

数据加载中...

2022/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/08

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/08

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/12/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/24

重要事件披露

8-K - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/06/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/01

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals